Publisher
Springer Science and Business Media LLC
Reference81 articles.
1. World Health Organization. Diabetes: fact sheet No 312. 2015. http://www.who.int/ . Accessed 26 Aug 2015.
2. Neumiller JJ. Incretin pharmacology: a review of the incretin effect and current incretin-based therapies. Cardiovasc Hematol Agents Med Chem. 2012;10(4):276–88.
3. Omar B, Ahren B. Pleiotropic mechanisms for the glucose-lowering action of DPP-4 inhibitors. Diabetes. 2014;63(7):2196–202.
4. US Food and Drug Administration. Onglyza (saxagliptin): US prescribing information. 2013. http://www.accessdata.fda.gov/ . Accessed 26 Aug 2015.
5. European Medicines Agency. Onglyza (saxagliptin): summary of product characteristics. 2015. http://www.ema.europa.eu/ . Accessed 26 Aug 2015.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献